Email updates

Keep up to date with the latest news and content from BMC Neuroscience and BioMed Central.

Open Access Highly Accessed Email this article to a friend

Drugs developed to treat diabetes, liraglutide and lixisenatide, cross the blood brain barrier and enhance neurogenesis

Kerry Hunter and Christian Hölscher*

BMC Neuroscience 2012, 13:33  doi:10.1186/1471-2202-13-33

Fields marked * are required


Multiple email addresses should be separated with commas or semicolons.
How can I ensure that I receive BMC Neuroscience's emails?